Clinical Trial Update: A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease [Phase 2]

View source ↗

Summary

This completed Phase 2 trial evaluated Triheptanoin as anaplerotic therapy for Huntington disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Huntington Disease | Phase 2 | Status: COMPLETED